Physicians with current and valid licenses in the United States, Canada, or Mexico who read any 3 of the selected continuing medical education (CME) articles in this issue of Archives of Dermatology, complete the CME Evaluation Form, and fax it to the number or mail it to the address at the bottom of the CME Evaluation Form are eligible for Category 1 CME credit. There is no charge.
The American Medical Association (AMA) is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. The AMA designates this educational activity for up to 1 hour of Category 1 credit per Archives of Dermatology issue toward the AMA Physician 's Recognition Award (PRA). Each physician should claim only those hours of credit that were actually spent in the educational activity.
Physicians with current and valid licenses in the United States, Mexico, or Canada are eligible for CME credit even if they live or practice in other countries. Physicians licensed in other countries are also welcome to participate in this CME activity. However, the PRA is only available to physicians licensed in the United States, Canada, or Mexico.
To earn credit, read the articles designated for CME credit carefully and complete the CME Evaluation Form. The CME Evaluation Form must be submitted within 3 months of the issue date. A certificate awarding 1 hour of Category 1 CME credit will be faxed or mailed to you; it is then your responsibility to maintain a record of credit received. Questions about CME processing should be directed to The Blackstone Group; tel: (312) 419-0400, ext 225; fax: (312) 269-1636.
One of our goals is to assess continually the educational needs of our readers so we may enhance the educational effectiveness of the Archives of Dermatology. To achieve this goal, we need your help. You must complete the CME Evaluation Form to receive credit.
For a complete description of the ARCHIVES' mission statement, please refer to the table of contents.
A flexible curriculum of article topics is developed annually by the journal's editorial board and is then supplemented throughout the year with information gained from readers, authors, reviewers, and editors. The Reader's Choice CME activity allows readers, as adult learners, to determine their own educational needs and to assist the editors in addressing their needs in future issues.
Readers of the Archives of Dermatology should be able to attain the following educational objectives: (1) select and read at least 3 articles per issue to gain new medical information on topics of particular interest to them as physicians, (2) assess its value to them as practicing physicians, and (3) think carefully about how this new information may influence their own practices.
The following articles in this issue may be read for CME credit:
Occult Neurofibroma and Increased S100 Protein in the Skin of Patients With Neurofibromatosis Type 1Article
Educational Objective: To learn that there was histologic evidence of subclinical disease in normal skin.
The Natural History of Chronic Actinic DermatitisArticle
Educational Objective: To learn about prognosis in this cohort of severely affected patients.
Tissue-Engineered Skin (Apligraf) in the Healing of Patients With Epidermolysis Bullosa WoundsArticle
Educational Objective: To learn that this modality is very effective in patients with epidermolysis bullosa.
Isotretinoin Use and Risk of Depression, Psychotic Symptoms, Suicide, and Attempted SuicideArticle
Educational Objective: To learn that there was not an increased risk of these disorders in this cohort.
Isolated Congenital Nail Dysplasia: A New Autosomal Dominant ConditionArticle
Educational Objective: To learn about this newly discribed entity.
Clinical and Genetic Studies of 3 Large, Consanguineous, Algerian Families With Mal de MeledaArticle
Educational Objective: To learn that in this family a single gene is responsible for this disorder.
Archives of Dermatology Reader's Choice: Continuing Medical Education. Arch Dermatol. 2000;136(10):1284-1285. doi:10-1001/pubs.Arch Dermatol.-ISSN-0003-987x-136-10-dcz10100